Terlipressin
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Institute of Liver and Biliary Sciences, India
Overview
Terlipressin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Terlipressin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Terlipressin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.